GlaxoSmithKline Pharma net up a tad on sluggish sales

July 26, 2010 10:07 AM EDT

 GlaxoSmithKline Pharmaceuticals reported a marginal 4 percent rise in quarterly profit on constraints in supply of vaccines due to global capacity crunch, the company and analysts said on Monday.

The drugmaker on Monday reported a net profit of 1.29 billion rupees for the April-June period on net sales of 4.98 billion rupees.

This compared to a profit of 1.24 billion rupees on sales of 4.57 billion rupees last year.

"On the top-line front, the nine percent growth is below expectations... and it was mainly due to the supply constraints in vaccines segment," Sushant Dalmia, analyst with Angel Broking, said, adding the smaller percentage rise in profit was primarily due sluggish sales.

The vaccines segment contributes about 10 percent of revenue for GlaxoSmithKline Pharma, another analyst with a Mumbai-based brokerage said.

Like us on Facebook

"This supply constraint problem has happened in the past, which is primarily due to rising demand not supported by manufacturing capacities globally," the analyst added.

Shares of GlaxoSmithKline Pharma were trading at 2,061.4 rupees, down 0.63 percent in a weak Mumbai market.

Copyright 2011 Thomson Reuters. All rights reserved.
Join the Conversation
Most popular
IBTimes TV

Tadashi Shoji Takes Mercedes-Benz Fashion Week 2012 to Another Era

Global Prenuers

Society
New York Giants Celebrate Super Bowl Victory With Manhattan Parade

Recommended for you
  1. Game studio Double Fine took to Kickstarter to fund its next adventure game project. In less than 24 hours, the crowdsourcing effort has raised more than $700,000.How Double Fine Raised $700,000 in 24 Hours With Crowdsourcing
  2. Samsung Galaxy S3 vs. HTC Edge: The Titans Come TogetherSamsung has witnessed extensive popularity over the months due to its Galaxy S2, which actually gave Apple's iPhone 4S a run for its money.